Theriva Biologics, Inc. (TOVX) AMEX

0.21

-0.007(-3.21%)

Updated at January 13 04:00PM

Currency In USD

Valuation

Market Cap2.36M
Enterprise Value-7.68M
P/E Ratio-0.05
PEG Ratio-0
Price/Sales Ratio46.25
Price/Book Ratio0.13
Enterprise/Revenue-24.32
Enterprise/EBITDA0.11

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin-191.92
Operating Margin-135.47

Management Effectiveness

Return On Assets-0.82
Return On Equity-1.69

Income Statement

Revenue0
Revenue/Share0.02
Gross Profit0
EBITDA-19.29M
Net Income-25.65M
Diluted EPS-19.03

Balance Sheet

Total Cash7.53M
Total Cash/Share1.79
Total Debt2.76M
Total Debt/Equity0.12
Current Ratio1.19
Book Value Per Share1.57

Price History

52-Week Change-88.95
52-Week High1.75
52-Week Low0.17
Moving Average 50 Days0.24
Moving Average 200 Days0.51

Statistics

Average Volume19.05M
Shares Outstanding33.76M
% Held by Institutions8.14

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:25
Last Split DateAugust 26, 2024